NTT/SAP
15.9.2016 11:13:23 CEST | Business Wire | Press release
SAP SE (NYSE:SAP) and Nippon Telegraph and Telephone Corporation (NTT) (NYSE:NTT) announced today its partnership enhancement in ‘Co-Innovation’, ‘Cross-Selling of Solutions’ and ‘Global Reference’.
SAP and NTT are collaborating by integrating cutting-edge technologies. As the first project of this initiative, to support safety operation of the transportation industry, the two companies have developed a solution combining SAP’s Connected Transportation Safety (CTS) solutions, which collects and analyzes vehicle related data, with NTT’s hitoe®, sensing fabric jointly developed with Toray Industries, and NTT IoT analytics platform, which provides driver’s biological data including heart rate and mental fatigue estimate, the project aims to provide more accurate and real-time information about vehicle and driver’s condition.
In cooperation with Keifuku Bus Co., Ltd (Fukui, Japan), SAP and NTT Group will conduct a field trial from October 2016, targeting to provide service from January 2017. The companies are planning to rollout this solution in the United States and Europe as well.
“We are honored to partner with NTT group who runs the world’s biggest data centers,” said Rob Enslin, member of the Executive Board of SAP SE and president of Global Customer Operations, SAP. “This partnership brings significant impact on SAP to broaden customers’ choice upon facilitating digital transformation. The integration of NTT’s cutting-edge technologies and SAP’s revolutionary solutions will generate momentum to elevate the overall market to the next level. By closely collaborating on a global scale, NTT and SAP will continuously strengthen ties to drive the three key initiatives including Co-innovation, Global Partnership, and SAP Solution Reference Customer in a long term perspective.”
“NTT aims to contribute to business transformation of its enterprise clients by providing high value-added services with partners.” said Jun Sawada, Senior Executive Vice President of NTT, “Global partnership with SAP is a significant step for strengthening our competitiveness in the rapidly changing ICT market. Through this partnership, along with SAP’s expertise and experiences, NTT can enhance its capabilities to support our global clients, and can accelerate digital transformation of industries.”
This co-innovation effort started in Palo Alto, California and has been led by NTT Labs and SAP Labs China. SAP and NTT Group intend to continue co-innovations in various areas with new technologies and expand its partnership through marketing promotion globally.
SAP and NTT Group have agreed to advance their digital practice collaboration and have formatted a new partner for Industrial Revolution. Primary target for 2016 is to move customers to the cloud for IoT and Industry 4.0.
While the partnership is not limited to Industrial Revolution, both companies are also accelerating their collaboration around private managed cloud solutions such as SAP HANA Enterprise Cloud leveraging NTT’s world class data center network around the globe. NTT is also a S/4 HANA Adoption Pinnacle Award Winner 2016.
In addition, NTT and SAP will create a global reference which could become a universal model. NTT has been working on establishing business platform as well as IT infrastructure to create synergy within the group. To accelerate the process, NTT is going to utilize the latest SAP solutions.
About SAP
As market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device – SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 320,000 customers to operate profitably, adapt continuously, and grow sustainably. The company is traded under the ‘SAP’ brand on the Frankfurt Stock Exchange, the New York Stock Exchange and other major global bourses. For more information, visit www.sap.com .
Copyright© 2016 SAP SE or an SAP affiliate company. All rights reserved.
SAP,
the SAP logo and other SAP products and services mentioned herein as
well as their respective logos are trademarks or registered trademarks
of SAP SE (or an SAP affiliate company) in Germany and other countries.
Other company names, logos, product names, etc. mentioned herein are the
registered trademarks or trademarks of the companies in question.
About Nippon Telegraph and Telephone Corporation (NTT)
NTT Group delivers advanced technology and innovative solutions in
networking, software communications, and cloud computing that help
transform businesses, governments and societies around the world.
NTT
Group will deliver convenient, enriched and reliable services to support
customers as a ‘Value Partner’ that its customers will continue to
select. Today, 85% of Fortune Global 100 companies rely on NTT Group as
their business partner. NTT Group generates over $95 billion in annual
revenues, has over 240 data centers and employs more than 241,000
professionals working in 87 countries. For more information, visit www.ntt-global.com
.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160915005612/en/
Contact:
Media Contacts
SAP Global PR
contact
Jason Loesche
j.loesche@sap.com
or
SAP
Japan Co., Ltd.
Kaori Suzuki, +81-(3) 6737-3880 (division
switchboard); +81-80-1007-5933 (direct line)
Public Relations
kaori.suzuki@sap.com
or
Nippon
Telegraph and Telephone Corporation
Public Relations Office
ntt-cnr-ml@hco.ntt.co.jp
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 07:30:00 CEST | Press release
SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
